Showing results (171-180 of 9,096) with videos related to
Sort By:
Pageof 910
Journal of Cellular and Molecular Medicine|January 12, 2020
Modulation of bile acid profile by gut microbiota in chronic hepatitis BXiaolin Wang, Lu Chen, Hui Wang, et al.Journal of Cellular and Molecular Medicine|January 3, 2020
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathwayXiaozhen Liu, Tao Jiang, Xuefei Li, et al.Journal of Cellular and Molecular Medicine|December 27, 2019
MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expressionCheng Wu, Chunqing Miao, Qingsheng Tang, et al.Journal of Cellular and Molecular Medicine|December 29, 2019
Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathwaysDe-Yi Yan, Jiahao Tang, Liang Chen, et al.Journal of Cellular and Molecular Medicine|December 29, 2019
An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysisYaoyi Xiong, Lushun Yuan, Jing Xiong, et al.Journal of Cellular and Molecular Medicine|December 19, 2019
PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cellsLu Ge, Huizhi Wang, Xiao Xu, et al.Journal of Cellular and Molecular Medicine|December 19, 2019
Emperipolesis mediated by CD8+ T cells correlates with biliary epithelia cell injury in primary biliary cholangitisSu-Xian Zhao, Wen-Cong Li, Na Fu, et al.Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemiaGiovanna Carrà, Paolo Nicoli, Marcello Francesco Lingua, et al.Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathwaySong Chen, Qiang Zhou, Zicheng Guo, et al.Journal of Cellular and Molecular Medicine|December 11, 2019
Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in miceZixiong Zhou, Jing Qi, Jing Zhao, et al.Pageof 910